Search

Search Constraints

You searched for: Author/Creator Mazard, Thibault

Search Results

1. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Issue 1 (December 2018)

2. Blood contains circulating cell‐free respiratory competent mitochondria. Issue 3 (19th January 2020)

3. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Issue 6 (30th October 2017)

4. Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study. (June 2022)

5. Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure. (March 2020)

6. Machine Learning‐Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening. Issue 18 (29th July 2020)

7. Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair. (6th January 2020)

8. Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment. Issue 9 (22nd June 2021)

9. RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study. Issue 2 (3rd November 2020)

10. Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. (February 2022)